Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00681044
What this trial is testing

HD Melphalan and SCT in Patients With IGDD or LCDD

Who this might be right for
Multiple Myeloma
Boston Medical Center 5
Not applicableStudy completedNCT00907452
What this trial is testing

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

Who this might be right for
Myeloma
Intergroupe Francophone du Myelome 143
Testing effectiveness (Phase 2)Ended earlyNCT01116128
What this trial is testing

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients

Who this might be right for
Myeloma
Fondazione EMN Italy Onlus 8
Large-scale testing (Phase 3)Ended earlyNCT01907009
What this trial is testing

A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)

Who this might be right for
Castrate Resistant Prostate Cancer
Barts & The London NHS Trust 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT01054196
What this trial is testing

Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 52
Testing effectiveness (Phase 2)Study completedNCT00003397
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Maryland, Baltimore 25
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00602706
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 76
Testing effectiveness (Phase 2)Ended earlyNCT00074269
What this trial is testing

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Diego 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04872595
What this trial is testing

A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphoid Leukemia (ALL)Myelodysplastic Syndromes (MDS)
Memorial Sloan Kettering Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00642395
What this trial is testing

Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 61
Early research (Phase 1)Study completedNCT00288028
What this trial is testing

Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 15
Early research (Phase 1)Study completedNCT00004056
What this trial is testing

Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 35
Early research (Phase 1)UnknownNCT00436761
What this trial is testing

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
Milton S. Hershey Medical Center 20
Early research (Phase 1)Ended earlyNCT01807286
What this trial is testing

Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 3
Large-scale testing (Phase 3)UnknownNCT00028886
What this trial is testing

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Commissie Voor Klinisch Toegepast Onderzoek 450
Testing effectiveness (Phase 2)Study completedNCT00472056
What this trial is testing

Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 93
Testing effectiveness (Phase 2)Ended earlyNCT03481556
What this trial is testing

Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM

Who this might be right for
Multiple Myeloma
Oncopeptides AB 56
Testing effectiveness (Phase 2)Study completedNCT00644371
What this trial is testing

Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 20
Testing effectiveness (Phase 2)Study completedNCT00001193
What this trial is testing

A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 200
Next Page